title: Pathologic myopia: where are we now?.
abstract: OBJECTIVE
  To describe current concepts and available treatments for pathologic myopia.
  
  
  METHODS
  Review of experimental and clinical studies.
  
  
  METHODS
  The demography, natural history, medical and surgical treatments for choroidal neovascular membrane, vitreoretinal interface disorders and future strategies for pathologic myopia are reviewed.
  
  
  RESULTS
  Several medical and surgical modalities are currently available to treat various complications of pathologic myopia. Macular translocation appears to stabilize or improve visual function in many eyes with choroidal neovascularization.
  
  
  CONCLUSIONS
  Newer strategies are emerging to better ameliorate or prevent the complications of pathologic myopia.
authors.affiliation: Department of Ophthalmology, Osaka University, Medical School, Osaka, Japan. tano@ophthal.med.osaka-u.ac.jp
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Tano
mesh_terms: D000818:Animals; D001284:Atrophy; D002829:Choroid / Q000473:pathology; D020256:Choroidal Neovascularization / Q000209:etiology / Q000473:pathology / Q000628:therapy; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D017075:Laser Coagulation; D008268:Macular Degeneration / Q000209:etiology / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009216:Myopia / Q000150:complications* / Q000473:pathology* / Q000628:therapy; D010778:Photochemotherapy; D012160:Retina / Q000473:pathology / Q000637:transplantation; D012167:Retinal Perforations / Q000209:etiology / Q000473:pathology / Q000628:therapy